Evidence map›Paper›PMID 42318475›Full record

ArticleFrontiers in oncology2026

Case Report: Inflammatory myofibroblastoma of the right forearm in an adult male: a clinical report.

Lanlan Li, Xiang Chang, Zhishuai Hu, Min Wang, Xiaoguang Huo, Wenzhe Xu

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lanlan LiZibo Central Hospital, Department of Rheumatology and Immunology, Shandong, China.
Xiang ChangZibo Central Hospital, Department of Medical Engineering, Shandong, China.
Zhishuai HuZibo Central Hospital, Department of Medical Engineering, Shandong, China.
Min WangZibo Central Hospital, Department of Vascular Surgery, Shandong, China.
Xiaoguang HuoZibo Central Hospital, Department of Ultrasound, Shandong, China.
Wenzhe XuZibo Central Hospital, Department of Ultrasound, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory myofibroblastoma (IMT) is rare, and cases located in the limbs are even rarer. We report a case of a 69-year-old Chinese male with a mass in the right forearm. It was surgically removed, and the pathology showed inflammatory myofibroblastoma. This case is reported due to its rare location. The purpose of this case report is to highlight the uniqueness of the case, collect and analyze the imaging characteristics of the disease, and provide assistance for daily clinical diagnosis and treatment. Case presentation: A 69-year-old male patient was reported with an inflammatory myofibroblastoma in the right forearm. A superficial ultrasound revealed a hypoechoic mass in the subcutaneous tissue of the right forearm. MRI showed a space-occupying lesion in the proximal subcutaneous area of the right forearm, and contrast-enhanced scanning was recommended for further evaluation. Postoperative pathological findings showed a malignant tumor of soft tissue origin in the right forearm, and immunohistochemistry suggested inflammatory myofibroblastoma. Conclusions: In summary, Inflammatory myofibroblastic tumor (IMT) in adults is a rare condition. When routine ultrasound or imaging detects limb masses, this disease should be considered.

Indexed as

adult maleforearmimaging diagnosisinflammatory myofibroblastomatreatment

Identifiers

PMID42318475
PMCPMC13272062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.